Yann Dean

1.1k total citations
16 papers, 774 citations indexed

About

Yann Dean is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Yann Dean has authored 16 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in Yann Dean's work include Complement system in diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (3 papers). Yann Dean is often cited by papers focused on Complement system in diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (3 papers). Yann Dean collaborates with scholars based in United Kingdom, Switzerland and Netherlands. Yann Dean's co-authors include Eamon P. McGreal, Philippe Gasque, B. Paul Morgan, Marie Kosco‐Vilbois, Frank M. Smith, G. O’Sullivan, Elizabeth Whitehead, Greg Elson, Graziano Pelli and Fabienne Burger and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Gastroenterology.

In The Last Decade

Yann Dean

16 papers receiving 742 citations

Peers

Countries citing papers authored by Yann Dean

Since Specialization

Citations

This map shows the geographic impact of Yann Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yann Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yann Dean more than expected).

Fields of papers citing papers by Yann Dean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yann Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yann Dean. The network helps show where Yann Dean may publish in the future.

Co-authorship network of co-authors of Yann Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Yann Dean. A scholar is included among the top collaborators of Yann Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yann Dean. Yann Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective 2015 ·Journal of Immunological Methods ·(unknown), C Berger, Pierre Cortez, Yann Dean, Julia Heinrich, Lisbeth Bjerring Jensen, (unknown), Stefan Kostense, Daniel Kramer, Sebastian Spindeldreher, Hishani Kirby	26
2	Characterization of a surrogate murine antibody to model anti-human CD3 therapies 2013 ·mAbs ·(unknown), Eric Hatterer, (unknown), Bruno Daubeuf, Laura Cons, Sophie Glatt, Walter Reith, Marie Kosco‐Vilbois, Yann Dean	7
3	Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins 2013 ·Pharmaceutical Research ·Vera Brinks, Daniel Weinbuch, Matthew Baker, Yann Dean, (unknown), Stefan Kostense, Bonita Rup, Wim Jiskoot	48
4	Long‐term amelioration of established collagen‐induced arthritis achieved with short‐term therapy combining anti‐CD3 and anti–tumor necrosis factor treatments 2012 ·Arthritis & Rheumatism ·(unknown), Eric Hatterer, Céline Lamacchia, Jean‐Marc Waldburger, Cem Gabay, Walter Reith, Marie Kosco‐Vilbois, Yann Dean	10
5	Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases 2012 ·Swiss Medical Weekly ·Yann Dean, (unknown), Marie Kosco‐Vilbois	19
6	Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohnʼs disease† 2010 ·Inflammatory Bowel Diseases ·C. Janneke van der Woude, Pieter Stokkers, Ad A. van Bodegraven, Gert Van Assche, (unknown), Leszek Paradowski, Geert D’Haens, Subrata Ghosh, Brian G. Feagan, Paul Rutgeerts, Gerard Dijkstra, Dirk J. de Jong, Bas Oldenburg, Mahdi Farhan, (unknown), Yann Dean, Daniël W. Hommes	33
7	493 Safety Profile and Signal of Efficacy of a Non-Fcr-Binding, Fully Human Anti-Cd3 Monoclonal Antibody in Patients with Moderate to Severe Crohn's Disease- Results of a Phase I/Iia, Double Blind, Placebo-Controlled, Randomized, Dose Escalation Study 2008 ·Gastroenterology ·C. Janneke van der Woude, Pieter Stokkers, Ad A. van Bodegraven, Gert A. Van Assche, (unknown), Leszek Paradowski, Geert D’Haens, Subrata Ghosh, Brian G. Feagan, Paul Rutgeerts, Gerard Dijkstra, Dirk J. de Jong, Bas Oldenburg, Mahdi Farhan, Yann Dean, Daniël W. Hommes	1
8	Pivotal Involvement of Fcγ Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1 2007 ·Journal of Biological Chemistry ·Irène Dunn-Siegrist, (unknown), Bruno Daubeuf, Yves Poitevin, (unknown), Suzanne Herren, Marie Kosco‐Vilbois, Yann Dean, Jérôme Pugin, Greg Elson	43
9	Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice 2006 ·Circulation ·Sabine Steffens, Fabienne Burger, Graziano Pelli, Yann Dean, Greg Elson, Marie Kosco‐Vilbois, Lucienne Chatenoud, François Mach	86
10	Roles of the Complement System in Human Neurodegenerative Disorders 2002 ·Molecular Neurobiology ·Philippe Gasque, J. W. Neal, Sim K. Singhrao, Eamon P. McGreal, Yann Dean, Johan van Beek, B. Paul Morgan	63
11	Endothelial cells, megakaryoblasts, platelets and alveolar epithelial cells express abundant levels of the mouse AA4 antigen, a C-type lectin-like receptor involved in homing activities and innate immune host defense 2001 ·European Journal of Immunology ·Yann Dean, Eamon P. McGreal, Philippe Gasque	28
12	Complement components of the innate immune system in health and disease in the CNS 2000 ·Immunopharmacology ·Philippe Gasque, Yann Dean, Eamon P. McGreal, (unknown), B. Paul Morgan	299
13	Molecular and Cellular Properties of the Rat AA4 Antigen, a C-type Lectin-like Receptor with Structural Homology to Thrombomodulin 2000 ·Journal of Biological Chemistry ·Yann Dean, Eamon P. McGreal, Hiroyasu Akatsu, Philippe Gasque	33
14	Role of the phagocytic C1qR (C1qRp) in the CNS: Identification of the signalling events following C1pRp crosslinking 2000 ·Immunopharmacology ·Eamon P. McGreal, Yann Dean, Carmen van den Berg, B. Paul Morgan, Philippe Gasque	1
15	An evaluation of gastric emptying times in pregnancy and the puerperium 1993 ·Anaesthesia ·Elizabeth Whitehead, Frank M. Smith, Yann Dean, G. O’Sullivan	76
16	The effect of a priming epidural injection of adrenaline on epidural blockade with bupivacaine 1991 ·Anaesthesia ·A. Baranowski, Yann Dean, Charles E. Pither	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact